Failure to detect an association between self-reported traumatic brain injury and Alzheimer’s disease neuropathology and dementia
By ACA |
Recent research with neuropathologic or biomarker evidence of Alzheimer's disease (AD) casts doubt on traumatic brain injury (TBI) as a ...
Read More GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer’s prevention studies
By ACA |
Recruitment for Alzheimer's disease (AD) prevention research studies is challenging because of lack of awareness among cognitively healthy adults coupled ...
Read More Clinical and cortical decline in the aphasic variant of Alzheimer’s disease
By ACA |
Primary progressive aphasia (PPA) displays variable progression trajectories that require further elucidation.
Read More Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer’s disease
By ACA |
The tau protein plays a central role in Alzheimer's disease (AD), and there is huge interest in measuring tau in ...
Read More Human stem cell–derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2
By ACA |
Murine microglia expressing the Alzheimer's disease–linked TREM2R47H mutation display variable decrease in phagocytosis, while impaired phagocytosis is reported following loss ...
Read More A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium
By ACA |
We explored regional brain atrophy patterns and their clinical correlates in dementia with Lewy bodies (DLB).
Read More Hypertension and obesity moderate the relationship between β-amyloid and cognitive decline in midlife
By ACA |
This study tested if central obesity, hypertension, or depressive symptoms moderated the relationship between β-amyloid (Aβ) and longitudinal cognitive performance ...
Read More AMYPAD Diagnostic and Patient Management Study: Rationale and design
By ACA |
Reimbursement of amyloid–positron emission tomography (PET) is lagging due to the lack of definitive evidence on its clinical utility and ...
Read More Withdrawn: Plasma concentrations of free amyloid-β cannot predict the development of Alzheimer’s disease
By ACA |
The Publisher regrets that this article is an accidental duplication of an article that has already been published, DOI of ...
Read More WITHDRAWN: Revisiting the cholinergic hypothesis in Alzheimer’s disease: Emerging evidence from translational and clinical research
By ACA |
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this ...
Read More